JUDY A WIENKE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner JEFFERSON CITY, MO NPI 1013988633

General Payments — all program years on this page

$1,692.75

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 93
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $336.93 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $336.9321

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $339.029
2022 $546.3232
2023 $470.4831
2024 $336.9321

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100267864 Novo Nordisk Inc $16.26 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100304871 Novo Nordisk Inc $13.08 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100486273 Novo Nordisk Inc $14.87 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100564912 Novo Nordisk Inc $15.14 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100586456 Novo Nordisk Inc $13.27 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116076651 GlaxoSmithKline, LLC. $13.72 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116202906 GlaxoSmithKline, LLC. $14.02 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116512155 GlaxoSmithKline, LLC. $13.87 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117717706 Amgen Inc. $13.47 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117717708 Amgen Inc. $19.59 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119213491 Otsuka America Pharmaceutical, Inc. $27.43 03/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124798534 Abbott Laboratories $17.23 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131641639 PFIZER INC. $14.45 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135647177 Lilly USA, LLC $15.15 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135718002 Lilly USA, LLC $20.85 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135718004 Lilly USA, LLC $15.97 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141758938 Merck Sharp & Dohme LLC $13.74 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143627829 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.48 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148372811 Axsome Therapeutics, Inc. $14.70 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151657307 Teva Pharmaceuticals USA, Inc. $18.63 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151657348 Teva Pharmaceuticals USA, Inc. $18.01 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.